Sanai Health Industry Group Valuation
Is 1889 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Por debajo del valor justo
Muy por debajo del valor justo
Price-To-Earnings vs. similares
Price-To-Earnings vs. Industria
PM vs. Ratio Justo
Pronóstico de los analistas
Share Price vs Fair Value
What is the Fair Price of 1889 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Por debajo del valor justo: 1889 (HK$0.05) cotiza por debajo de nuestra estimación de valor razonable (HK$0.94)
Muy por debajo del valor justo: 1889 cotiza por debajo de su valor razonable en más de un 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 1889?
Other financial metrics that can be useful for relative valuation.
| What is 1889's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CN¥106.79m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 1889's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 7.1x | ||
1643 Modern Chinese Medicine Group | 3.9x | n/a | HK$204.0m |
897 Wai Yuen Tong Medicine Holdings | 8.1x | n/a | HK$295.6m |
8329 Shenzhen Neptunus Interlong Bio-technique | 10.2x | n/a | HK$265.1m |
239 Pak Fah Yeow International | 6.1x | n/a | HK$645.1m |
1889 Sanai Health Industry Group | 5.7x | n/a | HK$115.6m |
Price-To-Earnings vs. similares: 1889 es un buen valor basado en su Ratio Price-To-Earnings (6.4x) comparado con la media de sus homólogos (7.1x).
Price to Earnings Ratio vs Industry
How does 1889's PE Ratio compare vs other companies in the HK Pharmaceuticals Industry?
Price-To-Earnings vs. Industria: 1889 es un buen valor basado en su Ratio Price-To-Earnings (4.3x) comparado con la media del sector Hong Kong Pharmaceuticals (7.5x).
Price to Earnings Ratio vs Fair Ratio
What is 1889's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 5.7x |
| Fair PE Ratio | n/a |
PM vs. Ratio Justo: Datos insuficientes para calcular 1889's Price-To-Earnings Fair Ratio para el análisis de valoración.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Pronóstico de los analistas: Datos insuficientes para mostrar el pronóstico de precios.